Back to Search Start Over

Parathyroid gland dysfunction in 22q11.2 deletion syndrome.

Authors :
Al-Jenaidi F
Makitie O
Grunebaum E
Sochett E
Source :
Hormone research [Horm Res] 2007; Vol. 67 (3), pp. 117-22. Date of Electronic Publication: 2006 Oct 19.
Publication Year :
2007

Abstract

Background: 22q11 deletion syndrome (22q11DS) is characterized by conotruncal cardiac defects and hypoplasia of parathyroid glands and thymus, which result in variable hypoparathyroidism (HPT) and immune deficiency.<br />Methods: To study the course of HPT and the spectrum of other associated manifestations we evaluated all patients with 22q11DS, confirmed by fluorescence in situ hybridization, and HPT who were under follow-up at the Calcium-bone clinic, The Hospital for Sick Children, Toronto. Patients were clinically assessed and their hospital records were reviewed.<br />Results: Eighteen patients were included. At follow-up assessment at median age of 7.3 years HPT was judged complete in 11 (61%) and partial in 7 patients (39%). Patients with complete HPT presented with hypocalcemia later (median age at diagnosis 2.4 vs. 0.0 years) and more often with a hypocalcemic seizure than patients with partial HPT (73 vs. 29%). The spectrum of other associated manifestations did not differ between the groups.<br />Conclusions: HPT in patients with 22q11DS is often partial. Many of the patients present with a hypocalcemic seizure which is predictive of complete HPT. Patients with complete and partial HPT do not differ in respect to their other associated features. Patients with features of 22q11DS should be actively screened for hypocalcemia to prevent development of symptomatic hypocalcemia.

Details

Language :
English
ISSN :
0301-0163
Volume :
67
Issue :
3
Database :
MEDLINE
Journal :
Hormone research
Publication Type :
Academic Journal
Accession number :
17057408
Full Text :
https://doi.org/10.1159/000096421